Evaluación de la toxicidad de la terapia combinada D-004 + tamsulosin en ratas

Pharmacological treatment of benign prostatic hyperplasia includes the use of α1- adrenoreceptors blockers, which mainly reduce lower urinary tract symptoms, and prostate 5α- reductase inhibitors, more effective for reducing prostate enlargement. This kind of therapy is, recommended for severe refractory cases or bot cases. It provides benefits of both therapeutic